Skip to main content

Alpha Blocker Versus Calcium Channel Blocker for Pheochromocytoma

  • Chapter
  • First Online:
Difficult Decisions in Endocrine Surgery

Abstract

The perioperative management of patients undergoing surgical resection of pheochromocytoma is essential to good outcomes. Historically high mortality rates associated with surgery have been mitigated by perioperative management of hemodynamics. Several options exist for the preoperative medical blockade of patients with catecholamine-producing tumors, including non-selective alpha-receptor blockers, selective alpha1-receptor blockers, and calcium channel blockers. In this chapter, we summarize the available data and provide recommendations for the optimal preoperative medical management of patients undergoing surgical resection of pheochromocytoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Welbourn RB. Early surgical history of phaeochromocytoma. Br J Surg. 1987;74(7):594–6.

    Article  CAS  PubMed  Google Scholar 

  2. Graham JB. Pheochromocytoma and hypertension; an analysis of 207 cases. Int Abstr Surg. 1951;92(2):105–21.

    PubMed  CAS  Google Scholar 

  3. Kvale WF, Manger WM, Priestley JT, Roth GM. Pheochromocytoma. Circulation. 1956;14(4 Part 1):622–30.

    Article  CAS  PubMed  Google Scholar 

  4. Kinney MA, Warner ME, vanHeerden JA, et al. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg. 2000;91(5):1118–23.

    PubMed  CAS  Google Scholar 

  5. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001;86(4):1480–6.

    PubMed  CAS  Google Scholar 

  6. Hamilton CA, Reid JL, Sumner DJ. Acute effects of phenoxybenzamine on alpha-adrenoceptor responses in vivo and in vitro: relation of in vivo pressor responses to the number of specific adrenoceptor binding sites. J Cardiovasc Pharmacol. 1983;5:868–73.

    Article  CAS  PubMed  Google Scholar 

  7. Bravo EL. Pheochromocytoma: an approach to antihypertensive management. Ann N Y Acad Sci. 2002;970:1–10.

    Article  CAS  PubMed  Google Scholar 

  8. Lehmann HU, Hochrein H, Witt E, Mies HW. Hemodynamic effects of calcium antagonists. Hypertension. 1983;5:1166–73.

    Article  Google Scholar 

  9. Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens. 2011;13:687–9.

    Article  CAS  Google Scholar 

  10. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the first international symposium. Nat Clin Pract Endocrinol Metab. 2007;3:92–102.

    Article  PubMed  Google Scholar 

  11. Chen H, Sippel RS, Pacak K. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma,paraganglioma & medullary thyroid cancer. Pancreas. 2010;39:775–83.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lenders JWM, Duh Q-Y, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915–42.

    Article  CAS  PubMed  Google Scholar 

  13. Jaeschke R, Guyatt GH, Dellinger P, Schunemann H, Levy MM, Kunz R, Norris S, Bion J. GRADE working group. Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ. 2008;337:a744.

    Article  PubMed  Google Scholar 

  14. Stenström G, Haljamäe H, Tisell LE. Influence of pre-operative treatment with phenoxybenzamine on the incidence of adverse cardiovascular reactions during anaesthesia and surgery for pheochromocytoma. Acta Anaesthesiol Scand. 1985;29:797–803.

    Article  PubMed  Google Scholar 

  15. Boutros AR, Bravo EL, Zanettin G, Straffon RA. Perioperative management of 63 patients with pheochromocytoma. Cleve Clin J Med. 1990;57(7):613.

    Article  CAS  PubMed  Google Scholar 

  16. Steinsapir J, Carr AA, Prisant M, Bransome ED Jr. Metyrosine and pheochromocytoma. Arch Intern Med. 1997;157:901–6.

    Article  CAS  PubMed  Google Scholar 

  17. Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC. Successful outcomes in pheochromocytoma surgery in the modern era. J Urol. 1999;161:764–7.

    Article  CAS  PubMed  Google Scholar 

  18. Shao Y, Chen R, Shen Z, et al. Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary? J Hypertens. 2011;29:2429–32.

    Article  CAS  PubMed  Google Scholar 

  19. Havlik RJ, Cahow E, Kinder BK. Advances in the diagnosis and treatment of pheochromocytoma. Arch Surg. 1988;123:626–30.

    Article  CAS  PubMed  Google Scholar 

  20. Russell WJ, Metcalfe IR, Tonkin AL, Frewin DB. The preoperative management of phaeochromocytoma. Anaesth Intensive Care. 1998;26:196–200.

    PubMed  CAS  Google Scholar 

  21. Kocak S, Aydintug S, Canakci N. α blockade in preoperative preparation of patients with pheochromocytomas. Int Surg. 2002;87:191–4.

    PubMed  Google Scholar 

  22. Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg. 2002;26:1037–42.

    Article  PubMed  Google Scholar 

  23. Bruynzeel H, Reelders RA, Groenland THN, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab. 2010;95:678–85.

    Article  CAS  PubMed  Google Scholar 

  24. Weingarden TN, Cata JP, O’Hara JF, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology. 2010;76:508e6–11.

    Google Scholar 

  25. Zhu Y, He H, Su T, et al. Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocrine. 2010;38:254–9.

    Article  CAS  PubMed  Google Scholar 

  26. Habbe N, Ruger F, Bojunga J, et al. Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method. World J Surg. 2013;37:1141–6.

    Article  PubMed  Google Scholar 

  27. Agrawal R, Mishra SK, Bhatia E, et al. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38:716–23.

    Article  PubMed  Google Scholar 

  28. Kiernan CM, Du L, Chen X, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21:3865–71.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Li J, Yang C-H. Improvement of preoperative management in patients with adrenal pheochromocytoma. Int J Clin Exp Med. 2014;7:5541–6.

    PubMed  PubMed Central  Google Scholar 

  30. Proye C, Thevenin D, Cecat P, et al. Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery. 1989;106:1149–54.

    PubMed  CAS  Google Scholar 

  31. Lebuffe G, Dosseh ED, Tek G, et al. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia. 2005;60:439–44.

    Article  CAS  PubMed  Google Scholar 

  32. Siddiqi HD, Yang H, Laird AM, et al. Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery. 2012;152:1027–36.

    Article  PubMed  Google Scholar 

  33. Brunaud L, Boutami M, Nguyen-Thi P-L, et al. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery. 2014;156:1410–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Glenda G. Callender .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holt, E., Malinowski, J., Callender, G.G. (2018). Alpha Blocker Versus Calcium Channel Blocker for Pheochromocytoma. In: Angelos, P., Grogan, R. (eds) Difficult Decisions in Endocrine Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-92860-9_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92860-9_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92858-6

  • Online ISBN: 978-3-319-92860-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics